Surgery · Breast (Benign, Carcinoma Breast, Staging, Treatment)

A 45-year-old woman with a 4 cm breast mass undergoes core biopsy showing invasive ductal carcinoma. Immunohistochemistry reveals ER-positive, PR-positive, HER2-negative, and Ki-67 index of 35%. According to the St. Gallen surrogate intrinsic subtype classification, what is the molecular subtype?

  • A Luminal A
  • B Triple negative
  • C HER2-enriched
  • D Luminal B (HER2-negative)
Correct answer: D. Luminal B (HER2-negative)

Explanation

Luminal D (HER2-negative) is defined as ER-positive, HER2-negative, with either high Ki-67 (≥20%) or low PR (<20%). A Ki-67 of 35% indicates high proliferative activity, distinguishing it from Luminal A, which has low Ki-67. HER2-enriched is ER-negative and HER2-positive. Triple negative lacks ER, PR, and HER2.

Reference: Harrison's Principles of Internal Medicine, 21st ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Breast (Benign, Carcinoma Breast, Staging, Treatment) MCQs

See all Breast (Benign, Carcinoma Breast, Staging, Treatment) MCQs →